DV
Dividend Vision

TLSA — Tiziana Life Sciences Ltd

Tiziana Life Sciences Ltd (TLSA)

Its deepest 1-year drawdown was 61.1%.

TLSA is an equity fund focused on a single company, Tiziana Life Sciences Ltd, a biotech firm. The fund lacks standard dividend distribution data and expense ratio information, making yield and cost metrics unavailable for analysis. This structure appeals primarily to investors seeking direct exposure to Tiziana's clinical-stage pipeline rather than those prioritizing regular income distributions.

TLSA key facts

Asset type
Stock
Asset class
Equity
Inception date
11/20/2018
Last close
$1.14
Market cap
$129,168,016
Average volume
991900.0
Beta
0.443
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.15